Name
OÜ Ülejõe Perearst
Registry code
10838106
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
04.04.2002 (22)
Financial year
01.01-31.12
Capital
3 448.00 €
Activity
86211 - Provision of general medical treatment
1 261 368 €
278 989 €
22%
2 408 €
(estimate is approximate)
434 284 €
16
Submitted
No tax arrears
64%
53%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Tatjana Tšuhnenkova 21.12.1960 (63) | 33% - 1 150.00 EUR | Board member | Direct ownership | Founder |
| Aima Olvik 28.04.1960 (64) | 33% - 1 149.00 EUR | Board member | Direct ownership | Founder |
| Madli Alanurm 09.05.1983 (41) | 33% - 1 149.00 EUR | - | - | |
| Antares Aver 16.12.1951 (72) | - | - | Direct ownership | |
| Marju Punane 23.12.1943 (80) | - | - | - | Founder |
| 2019 25.03.2020 | 2020 25.03.2021 | 2021 01.04.2022 | 2022 21.02.2023 | 2023 27.03.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 836 251 € | 937 850 € | 1 043 383 € | 1 078 653 € | 1 261 368 € |
| Net profit (loss) for the period | 140 420 € | 231 003 € | 258 582 € | 182 700 € | 278 989 € |
| Profit Margin | 17% | 25% | 25% | 17% | 22% |
| Current Assets | 272 848 € | 343 200 € | 438 749 € | 405 544 € | 524 950 € |
| Fixed Assets | 6 078 € | 5 110 € | 4 755 € | 5 807 € | 4 452 € |
| Total Assets | 278 926 € | 348 310 € | 443 504 € | 411 351 € | 529 402 € |
| Current Liabilities | 69 617 € | 64 297 € | 80 909 € | 76 056 € | 95 118 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 209 309 € | 284 013 € | 362 595 € | 335 295 € | 434 284 € |
| Employees | 14 | 15 | 15 | 16 | 16 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 68 196.11 € | 73 293.08 € | 16 |
| 2023 Q4 | - | 48 569.07 € | 52 217.16 € | 17 |
| 2023 Q3 | - | 66 108.08 € | 70 957.51 € | 15 |
| 2023 Q2 | - | 50 559.94 € | 54 186.73 € | 19 |
| 2023 Q1 | - | 100 124.36 € | 75 109.35 € | 17 |
| 2022 Q4 | - | 43 508.67 € | 46 745.08 € | 16 |
| 2022 Q3 | - | 62 374.52 € | 66 944.35 € | 14 |
| 2022 Q2 | - | 92 608.56 € | 58 332.93 € | 16 |
| 2022 Q1 | - | 61 638.71 € | 66 305.05 € | 15 |
| 2021 Q4 | - | 37 819.67 € | 40 690.13 € | 16 |
| 2021 Q3 | - | 53 753.08 € | 58 254.99 € | 16 |
| 2021 Q2 | - | 84 376.06 € | 55 261.01 € | 18 |
| 2021 Q1 | - | 48 418.05 € | 52 560.63 € | 14 |
| 2020 Q4 | - | 34 844.7 € | 37 903.63 € | 15 |
| 2020 Q3 | - | 50 195.8 € | 54 513.85 € | 14 |
| 2020 Q2 | - | 75 740.13 € | 47 718.5 € | 14 |
| 2020 Q1 | - | 44 341.43 € | 47 790.07 € | 15 |
